Eudocia Quant, MD-Center for Neuro-Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Boston, MassachusettsDr. Eudocia Quant earned her medical degree from Washington University School of Medicine in 2003. She subsequently completed her residency in neurology at the combined Brigham and Women’s/Masschusetts General Hospital program and her fellowship in neuro-oncology at Dana Farber Cancer Institute/Massachusetts General Hospital. Following fellowship, she joined the faculty at Dana Farber. Dr. Quant is board certified in neurology. Her clinical and research interest include biomarkers in glioblastomas, brain metastases and neurologic complications of cancer.

Written by a medical oncologist, Dx/Rx: Brain Tumors is a concise, pocket-sized guide that provides essential information on the diagnosis and management of brain tumors. From tumors affecting the central and peripheral nervous systems to neurologic complications of cancer and cancer therapies, it covers the major topics in neuro-oncology and is ideal for internists, neurologists, and oncologists. It is a must-have reference for on the ward or in the clinic!

Key features include:

• Up-to-date review of major topics in neuro-oncology, presented in a concise, easy-to-read format
• In-depth discussion of tumors affecting the central and peripheral nervous systems, such as gliomas, meningiomas, brain  metastases and neoplastic meningitis
• Treatment strategies for the most common tumors
• Essential information about neurologic complications of cancer and cancer therapies, including cognitive impairment from chemotherapy and radiation, peripheral neuropathy, paraneoplastic disorders, strokes and seizures

Download